Abstract
Apoptosis plays a key role in the pathogenesis in a variety of cardiovascular diseases due to loss of terminally differentiated cardiac myocytes. Cardiac myocytes undergoing apoptosis have been identified in tissue samples from patients suffering from myocardial infarction, diabetic cardiomyopathy, and end-stage congestive heart failure. Apoptosis is a highly regulated program of cell death and can be mediated by death receptors in the plasma membrane, as well as the mitochondria and the endoplasmic reticulum. The cell death program is activated in cardiac myocytes by various stressors including cytokines, increased oxidative stress and DNA damage. Many studies have demonstrated that inhibition of apoptosis is cardioprotective and can prevent the development of heart failure. This review provides a current overview of the evidence of apoptosis in cardiovascular diseases and discusses the molecular pathways involved in cardiac myocyte apoptosis.
Similar content being viewed by others
References
Reggiori F, Klionsky DJ (2005) Autophagosomes: biogenesis from scratch? Curr Opin Cell Biol 17:415–422. doi:10.1016/j.ceb.2005.06.007
Kitsis RN, Peng CF, Cuervo AM (2007) Eat your heart out. Nat Med 13:539–541. doi:10.1038/nm0507-539
Schweichel JU, Merker HJ (1973) The morphology of various types of cell death in prenatal tissues. Teratology 7:253–266. doi:10.1002/tera.1420070306
Searle J, Kerr JF, Bishop CJ (1982) Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu 17(Pt 2):229–259
Kerr JF (1971) Shrinkage necrosis: a distinct mode of cellular death. J Pathol 105:13–20. doi:10.1002/path.1711050103
Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3–15
Rich T, Watson CJ, Wyllie A (1999) Apoptosis: the germs of death. Nat Cell Biol 1:E69–E71. doi:10.1038/11038
Savill J, Fadok V (2000) Corpse clearance defines the meaning of cell death. Nature 407:784–788. doi:10.1038/35037722
Olivetti G, Quaini F, Sala R et al (1996) Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 28:2005–2016. doi:10.1006/jmcc.1996.0193
Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM (1997) Apoptosis in human acute myocardial infarction. Circulation 95:320–323
Narula J, Haider N, Virmani R et al (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182–1189. doi:10.1056/NEJM199610173351603
Aharinejad S, Andrukhova O, Lucas T et al (2008) Programmed cell death in idiopathic dilated cardiomyopathy is mediated by suppression of the apoptosis inhibitor Apollon. Ann Thorac Surg 86:109–114. doi:10.1016/j.athoracsur.2008.03.057 discussion 114
Cheng W, Kajstura J, Nitahara JA et al (1996) Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226:316–327. doi:10.1006/excr.1996.0232
Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94:1621–1628. doi:10.1172/JCI117504
Gao HK, Yin Z, Zhou N, Feng XY, Gao F, Wang HC (2008) Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia–reperfusion injury via inhibition of inflammation and apoptosis. J Cardiovasc Pharmacol 52:286–292. doi:10.1097/FJC.0b013e318186a84d
Kubota T, McTiernan CF, Frye CS et al (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81:627–635
Bryant D, Becker L, Richardson J et al (1998) Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97:1375–1381
Sayen MR, Gustafsson AB, Sussman MA, Molkentin JD, Gottlieb RA (2003) Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production. Am J Physiol Cell Physiol 284:C562–C570
Wang J, Silva JP, Gustafsson CM, Rustin P, Larsson NG (2001) Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci USA 98:4038–4043. doi:10.1073/pnas.061038798
Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG (1998) Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97:2307–2315
Clarke MC, Littlewood TD, Figg N et al (2008) Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 102:1529–1538. doi:10.1161/CIRCRESAHA.108.175976
Matsumura K, Jeremy RW, Schaper J, Becker LC (1998) Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 97:795–804
Takemura G, Ohno M, Hayakawa Y et al (1998) Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 82:1130–1138
Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29–34. doi:10.1016/0002-9149(74)90089-7
Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ (2002) Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51:1938–1948. doi:10.2337/diabetes.51.6.1938
Li Z, Zhang T, Dai H et al (2007) Involvement of endoplasmic reticulum stress in myocardial apoptosis of streptozocin-induced diabetic rats. J Clin Biochem Nutr 41:58–67. doi:10.3164/jcbn.2007008
Mukamal KJ, Nesto RW, Cohen MC et al (2001) Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 24:1422–1427. doi:10.2337/diacare.24.8.1422
Backlund T, Palojoki E, Saraste A et al (2004) Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes. Diabetologia 47:325–330. doi:10.1007/s00125-003-1311-5
Kuethe F, Sigusch HH, Bornstein SR, Hilbig K, Kamvissi V, Figulla HR (2007) Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy? Horm Metab Res 39:672–676. doi:10.1055/s-2007-985823
Cai L, Kang YJ (2001) Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 1:181–193. doi:10.1385/CT:1:3:181
Song Y, Wang J, Li Y et al (2005) Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury. Am J Pathol 167:17–26
Ye G, Metreveli NS, Ren J, Epstein PN (2003) Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52:777–783. doi:10.2337/diabetes.52.3.777
Guerra S, Leri A, Wang X et al (1999) Myocyte death in the failing human heart is gender dependent. Circ Res 85:856–866
Wencker D, Chandra M, Nguyen K et al (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497–1504
Thorburn A (2004) Death receptor-induced cell killing. Cell Signal 16:139–144. doi:10.1016/j.cellsig.2003.08.007
Liao X, Wang X, Gu Y, Chen Q, Chen LY (2005) Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis. Life Sci 77:160–174. doi:10.1016/j.lfs.2004.11.029
Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236–241
Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK (1993) Tumour necrosis factor alpha in severe congestive cardiac failure. Br Heart J 70:141–143. doi:10.1136/hrt.70.2.141
Ferrari R, Bachetti T, Confortini R et al (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92:1479–1486
Testa M, Yeh M, Lee P et al (1996) Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28:964–971. doi:10.1016/S0735-1097(96)00268-9
Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B (1992) The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 90:693–698. doi:10.1172/JCI115939
Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL (1995) Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96:1042–1052. doi:10.1172/JCI118090
Jeremias I, Kupatt C, Martin-Villalba A et al (2000) Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 102:915–920
Torre-Amione G, Kapadia S, Lee J et al (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704–711
Doyama K, Fujiwara H, Fukumoto M et al (1996) Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure. Int J Cardiol 54:217–225. doi:10.1016/0167-5273(96)02607-1
Gilles S, Zahler S, Welsch U, Sommerhoff CP, Becker BF (2003) Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res 60:608–616. doi:10.1016/j.cardiores.2003.08.016
Tanaka M, Ito H, Adachi S et al (1994) Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 75:426–433
Meldrum DR (1998) Tumor necrosis factor in the heart. Am J Physiol 274:R577–R595
Seko Y, Kayagaki N, Seino K, Yagita H, Okumura K, Nagai R (2002) Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3. J Am Coll Cardiol 39:1399–1403. doi:10.1016/S0735-1097(02)01776-X
Lee P, Sata M, Lefer DJ, Factor SM, Walsh K, Kitsis RN (2003) Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia–reperfusion in vivo. Am J Physiol Heart Circ Physiol 284:H456–H463
Li Y, Takemura G, Kosai K et al (2004) Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ Res 95:627–636. doi:10.1161/01.RES.0000141528.54850.bd
Gomez L, Chavanis N, Argaud L et al (2005) Fas-independent mitochondrial damage triggers cardiomyocyte death after ischemia–reperfusion. Am J Physiol Heart Circ Physiol 289:H2153–H2158. doi:10.1152/ajpheart.00165.2005
Bhuiyan MS, Takada Y, Shioda N, Moriguchi S, Kasahara J, Fukunaga K (2008) Cardioprotective effect of vanadyl sulfate on ischemia/reperfusion-induced injury in rat heart in vivo is mediated by activation of protein kinase B and induction of FLICE-inhibitory protein. Cardiovasc Ther 26:10–23
Niu J, Azfer A, Deucher MF, Goldschmidt-Clermont PJ, Kolattukudy PE (2006) Targeted cardiac expression of soluble FAS prevents the development of heart failure in mice with cardiac-specific expression of MCP-1. J Mol Cell Cardiol 40:810–820. doi:10.1016/j.yjmcc.2006.03.010
Scarabelli TM, Stephanou A, Pasini E et al (2002) Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ Res 90:745–748. doi:10.1161/01.RES.0000015224.07870.9A
Gustafsson AB, Tsai JG, Logue SE, Crow MT, Gottlieb RA (2004) Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation. J Biol Chem 279:21233–21238. doi:10.1074/jbc.M400695200
Chen M, Won DJ, Krajewski S, Gottlieb RA (2002) Calpain and mitochondria in ischemia/reperfusion injury. J Biol Chem 277:29181–29186. doi:10.1074/jbc.M204951200
Hamacher-Brady A, Brady NR, Logue SE et al (2007) Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 14:146–157. doi:10.1038/sj.cdd.4401936
Iliodromitis EK, Lazou A, Kremastinos DT (2007) Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vasc Health Risk Manag 3:629–637
Imahashi K, Schneider MD, Steenbergen C, Murphy E (2004) Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res 95:734–741. doi:10.1161/01.RES.0000143898.67182.4c
Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205–219. doi:10.1016/S0092-8674(04)00046-7
Huang DC, Strasser A (2000) BH3-Only proteins-essential initiators of apoptotic cell death. Cell 103:839–842. doi:10.1016/S0092-8674(00)00187-2
Reeve JL, Szegezdi E, Logue SE et al (2007) Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xL. J Cell Mol Med 11:509–520. doi:10.1111/j.1582-4934.2007.00042.x
Kirshenbaum LA, de Moissac D (1997) The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 96:1580–1585
Zhang D, Mott JL, Chang SW, Stevens M, Mikolajczak P, Zassenhaus HP (2005) Mitochondrial DNA mutations activate programmed cell survival in the mouse heart. Am J Physiol Heart Circ Physiol 288:H2476–H2483. doi:10.1152/ajpheart.00670.2004
Brocheriou V, Hagege AA, Oubenaissa A et al (2000) Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med 2:326–333. doi:10.1002/1521-2254(200009/10)2:5<326::AID-JGM133>3.0.CO;2-1
Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH (2001) Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 280:H2313–H2320
Gustafsson AB, Gottlieb RA (2007) Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 292:C45–C51
Milner DJ, Taffet GE, Wang X et al (1999) The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. J Mol Cell Cardiol 31:2063–2076. doi:10.1006/jmcc.1999.1037
Weisleder N, Taffet GE, Capetanaki Y (2004) Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy. Proc Natl Acad Sci USA 101:769–774. doi:10.1073/pnas.0303202101
Karmazyn M, Moffat MP (1993) Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res 27:915–924. doi:10.1093/cvr/27.6.915
Zhu L, Yu Y, Chua BH, Ho YS, Kuo TH (2001) Regulation of sodium–calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice. J Mol Cell Cardiol 33:2135–2144. doi:10.1006/jmcc.2001.1476
Rouslin W, Erickson JL, Solaro RJ (1986) Effects of oligomycin and acidosis on rates of ATP depletion in ischemic heart muscle. Am J Physiol 250:H503–H508
Imahashi K, Schneider M, Steenbergen C, Murphy E (2004) BCL-2 reduces acidification and the fall in ATP during Ischaemia. Cardiovasc J S Afr 15:S3
Kubli DA, Quinsay MN, Huang C, Lee Y, Gustafsson AB (2008) Bnip3 functions as a mitochondrial sensor of oxidative stress during myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 295(5):H2025–H2031
Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14–3-3 not BCL-X(L). Cell 87:619–628. doi:10.1016/S0092-8674(00)81382-3
Wei MC, Zong WX, Cheng EH et al (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727–730. doi:10.1126/science.1059108
Kubli DA, Ycaza JE, Gustafsson AB (2007) Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak. Biochem J 405:407–415. doi:10.1042/BJ20070319
Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB (2001) BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 15:1481–1486. doi:10.1101/gad.897601
Capano M, Crompton M (2006) Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases. Biochem J 395:57–64. doi:10.1042/BJ20051654
Hamacher-Brady A, Brady NR, Gottlieb RA (2006) Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 281:29776–29787. doi:10.1074/jbc.M603783200
Hochhauser E, Kivity S, Offen D et al (2003) Bax ablation protects against myocardial ischemia–reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol 284:H2351–H2359
Diwan A, Krenz M, Syed FM et al (2007) Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Invest 117:2825–2833. doi:10.1172/JCI32490
Bruick RK (2000) Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 97:9082–9087. doi:10.1073/pnas.97.16.9082
Yurkova N, Shaw J, Blackie K et al (2008) The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes. Circ Res 102:472–479. doi:10.1161/CIRCRESAHA.107.164731
Frazier DP, Wilson A, Graham RM, Thompson JW, Bishopric NH, Webster KA (2006) Acidosis regulates the stability, hydrophobicity, and activity of the BH3-only protein Bnip3. Antioxid Redox Signal 8:1625–1634. doi:10.1089/ars.2006.8.1625
Regula KM, Ens K, Kirshenbaum LA (2002) Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 91:226–231. doi:10.1161/01.RES.0000029232.42227.16
Vande VC, Cizeau J, Dubik D et al (2000) BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 20:5454–5468. doi:10.1128/MCB.20.15.5454-5468.2000
Diwan A, Wansapura J, Syed FM, Matkovich SJ, Lorenz JN, Dorn GW II (2008) Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation. Circulation 117:396–404. doi:10.1161/CIRCULATIONAHA.107.727073
Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA (2001) Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J Biol Chem 276:30724–30728. doi:10.1074/jbc.M103701200
Murriel CL, Churchill E, Inagaki K, Szweda LI, Mochly-Rosen D (2004) Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem 279:47985–47991. doi:10.1074/jbc.M405071200
Latif N, Khan MA, Birks E et al (2000) Upregulation of the Bcl-2 family of proteins in end stage heart failure. J Am Coll Cardiol 35:1769–1777. doi:10.1016/S0735-1097(00)00647-1
Di Napoli P, Taccardi AA, Grilli A et al (2003) Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy. Am Heart J 146:1105–1111. doi:10.1016/S0002-8703(03)00445-9
Baldi A, Abbate A, Bussani R et al (2002) Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 34:165–174. doi:10.1006/jmcc.2001.1498
Sharma AK, Dhingra S, Khaper N, Singal PK (2007) Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs. Am J Physiol Heart Circ Physiol 293:H1384–H1390. doi:10.1152/ajpheart.00553.2007
Li P, Nijhawan D, Budihardjo I et al (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489. doi:10.1016/S0092-8674(00)80434-1
Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW (2002) Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell 9:423–432. doi:10.1016/S1097-2765(02)00442-2
Jiang X, Wang X (2000) Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 275:31199–31203. doi:10.1074/jbc.C000405200
Pacher P, Szabo C (2007) Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 25:235–260. doi:10.1111/j.1527-3466.2007.00018.x
de Boer RA, van Veldhuisen DJ, van der Wijk J et al (2000) Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J Card Fail 6:330–337. doi:10.1054/jcaf.2000.20457
Vahsen N, Cande C, Briere JJ et al (2004) AIF deficiency compromises oxidative phosphorylation. EMBO J 23:4679–4689. doi:10.1038/sj.emboj.7600461
Joza N, Oudit GY, Brown D et al (2005) Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol 25:10261–10272. doi:10.1128/MCB.25.23.10261-10272.2005
van Empel VP, Bertrand AT, van der Nagel R et al (2005) Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ Res 96:e92–e101. doi:10.1161/01.RES.0000172081.30327.28
Norberg E, Gogvadze V, Ott M et al (2008) An increase in intracellular Ca(2+) is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ 15(12):1857–1864
Daugas E, Susin SA, Zamzami N et al (2000) Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14:729–739
Halestrap AP (2006) Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 34:232–237. doi:10.1042/BST20060232
Garcia-Rivas Gde J, Carvajal K, Correa F, Zazueta C (2006) Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo. Br J Pharmacol 149:829–837. doi:10.1038/sj.bjp.0706932
Wang J, Zhang Z, Hu Y et al (2007) SEA0400, a novel Na(+)/Ca(2 +) exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes. Physiol Res 56:17–23
Kim GT, Chun YS, Park JW, Kim MS (2003) Role of apoptosis-inducing factor in myocardial cell death by ischemia–reperfusion. Biochem Biophys Res Commun 309:619–624. doi:10.1016/j.bbrc.2003.08.045
Song ZF, Ji XP, Li XX, Wang SJ, Wang SH, Zhang Y (2008) Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia/reperfusion injury via suppressing JNK-mediated AIF translocation. J Cell Mol Med 12:1220–1228. doi:10.1111/j.1582-4934.2008.00183.x
Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16:6914–6925. doi:10.1093/emboj/16.23.6914
Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300–304. doi:10.1038/40901
Liu HR, Gao E, Hu A et al (2005) Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion. Circulation 111:90–96. doi:10.1161/01.CIR.0000151613.90994.17
Bhuiyan MS, Fukunaga K (2007) Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo. Eur J Pharmacol 557:168–177. doi:10.1016/j.ejphar.2006.10.067
Chua CC, Gao J, Ho YS et al (2007) Overexpression of IAP-2 attenuates apoptosis and protects against myocardial ischemia/reperfusion injury in transgenic mice. Biochim Biophys Acta 1773:577–583
Ikeda S, Ozaki K (1997) Action of mitochondrial endonuclease G on DNA damaged by L-ascorbic acid, peplomycin, and cis-diamminedichloroplatinum (II). Biochem Biophys Res Commun 235:291–294. doi:10.1006/bbrc.1997.6786
Javadov S, Choi A, Rajapurohitam V, Zeidan A, Basnakian AG, Karmazyn M (2008) NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Cardiovasc Res 77:416–424. doi:10.1093/cvr/cvm039
Bahi N, Zhang J, Llovera M, Ballester M, Comella JX, Sanchis D (2006) Switch from caspase-dependent to caspase-independent death during heart development: essential role of endonuclease G in ischemia-induced DNA processing of differentiated cardiomyocytes. J Biol Chem 281:22943–22952. doi:10.1074/jbc.M601025200
Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7:880–885. doi:10.1038/sj.embor.7400779
Xu C, Bailly-Maitre B, Reed JC (2005) Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115:2656–2664. doi:10.1172/JCI26373
Okada K, Minamino T, Tsukamoto Y et al (2004) Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110:705–712. doi:10.1161/01.CIR.0000137836.95625.D4
Szegezdi E, Duffy A, O’Mahoney ME et al (2006) ER stress contributes to ischemia-induced cardiomyocyte apoptosis. Biochem Biophys Res Commun 349:1406–1411. doi:10.1016/j.bbrc.2006.09.009
Thuerauf DJ, Marcinko M, Gude N, Rubio M, Sussman MA, Glembotski CC (2006) Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ Res 99:275–282. doi:10.1161/01.RES.0000233317.70421.03
Azfer A, Niu J, Rogers LM, Adamski FM, Kolattukudy PE (2006) Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. Am J Physiol Heart Circ Physiol 291:H1411–H1420. doi:10.1152/ajpheart.01378.2005
Jackson CV, McGrath GM, Tahiliani AG, Vadlamudi RV, McNeill JH (1985) A functional and ultrastructural analysis of experimental diabetic rat myocardium.Manifestation of a cardiomyopathy. Diabetes 34:876–883. doi:10.2337/diabetes.34.9.876
Hamada H, Suzuki M, Yuasa S et al (2004) Dilated cardiomyopathy caused by aberrant endoplasmic reticulum quality control in mutant KDEL receptor transgenic mice. Mol Cell Biol 24:8007–8017. doi:10.1128/MCB.24.18.8007-8017.2004
Breckenridge DG, Germain M, Mathai JP, Nguyen M, Shore GC (2003) Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22:8608–8618. doi:10.1038/sj.onc.1207108
Qi X, Vallentin A, Churchill E, Mochly-Rosen D (2007) deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart. J Mol Cell Cardiol 43:420–428. doi:10.1016/j.yjmcc.2007.07.061
Toth A, Jeffers JR, Nickson P et al (2006) Targeted deletion of puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion. Am J Physiol Heart Circ Physiol 291(1):H52–H60
Nickson P, Toth A, Erhardt P (2007) PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress. Cardiovasc Res 73:48–56. doi:10.1016/j.cardiores.2006.10.001
Scorrano L, Oakes SA, Opferman JT et al (2003) BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300:135–139. doi:10.1126/science.1081208
Luo X, Budihardjo I, Zou H, Slaughter C, Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481–490. doi:10.1016/S0092-8674(00)81589-5
Li H, Zhu H, Xu CJ, Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491–501. doi:10.1016/S0092-8674(00)81590-1
Date T, Mochizuki S, Belanger AJ et al (2003) Differential effects of membrane and soluble Fas ligand on cardiomyocytes: role in ischemia/reperfusion injury. J Mol Cell Cardiol 35:811–821. doi:10.1016/S0022-2828(03)00139-1
Haudek SB, Taffet GE, Schneider MD, Mann DL (2007) TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 117:2692–2701. doi:10.1172/JCI29134
Kalai M, Lamkanfi M, Denecker G et al (2003) Regulation of the expression and processing of caspase-12. J Cell Biol 162:457–467. doi:10.1083/jcb.200303157
Bajaj G, Sharma RK (2006) TNF-alpha-mediated cardiomyocyte apoptosis involves caspase-12 and calpain. Biochem Biophys Res Commun 345:1558–1564. doi:10.1016/j.bbrc.2006.05.059
Gyan E, Frisan E, Beyne-Rauzy O et al (2008) Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum. Leukemia 22:1864–1873. doi:10.1038/leu.2008.172
Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC (2003) Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol 160:1115–1127. doi:10.1083/jcb.200212059
Mathai JP, Germain M, Shore GC (2005) BH3-only BIK regulates BAX, BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. J Biol Chem 280:23829–23836. doi:10.1074/jbc.M500800200
Nakai A, Yamaguchi O, Takeda T et al (2007) The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13:619–624. doi:10.1038/nm1574
Matsui Y, Takagi H, Qu X et al (2007) Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 100:914–922. doi:10.1161/01.RES.0000261924.76669.36
Zhu H, Tannous P, Johnstone JL et al (2007) Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 117:1782–1793. doi:10.1172/JCI27523
Yan L, Vatner DE, Kim SJ et al (2005) Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 102:13807–13812. doi:10.1073/pnas.0506843102
Yousefi S, Perozzo R, Schmid I et al (2006) Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 8:1124–1132. doi:10.1038/ncb1482
Pyo JO, Jang MH, Kwon YK et al (2005) Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem 280:20722–20729. doi:10.1074/jbc.M413934200
Pattingre S, Tassa A, Qu X et al (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122:927–939. doi:10.1016/j.cell.2005.07.002
Maiuri MC, Criollo A, Tasdemir E et al (2007) BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 3:374–376
Rashmi R, Pillai SG, Vijayalingam S, Ryerse J, Chinnadurai G (2008) BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells. Oncogene 27:1366–1375. doi:10.1038/sj.onc.1210783
Akar U, Chaves-Reyez A, Barria M et al (2008) Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 4:669–679
Ray R, Chen G, Vande VC et al (2000) BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem 275:1439–1448. doi:10.1074/jbc.275.2.1439
Acknowledgments
This manuscript was supported by a Scientist Development Award from AHA, and NIH grant HL087023 to Å. B. G.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, Y., Gustafsson, Å.B. Role of apoptosis in cardiovascular disease. Apoptosis 14, 536–548 (2009). https://doi.org/10.1007/s10495-008-0302-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-008-0302-x